Do analysts prefer TMDIF or MDAI?

Spectral AI has a consensus price target of $4.00, indicating a potential upside of 140.96%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts clearly believe Spectral AI is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Spectral AI 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Do analysts recommend TMDIF or SRTS?

Sensus Healthcare has a consensus target price of $5.83, indicating a potential upside of 92.52%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Sensus Healthcare 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Do analysts recommend TMDIF or POCI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend BDMD or TMDIF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings & valuation, BDMD or TMDIF?

Titan Medical has lower revenue, but higher earnings than Baird Medical Investment. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 1.48 N/A N/A N/A Titan Medical $17.63M 0.71 $6.95M $0.05 2.20

Is BDMD or TMDIF more profitable?

Baird Medical Investment's return on equity of 0.00% beat Titan Medical's return on equity. Company Net Margins Return on Equity Return on Assets Baird Medical Investment N/A N/A N/A Titan Medical N/A -82.31% -51.47%

Do analysts rate TELA or TMDIF?

TELA Bio presently has a consensus target price of $2.20, indicating a potential upside of 69.23%. Given TELA Bio's stronger consensus rating and higher probable upside, equities analysts plainly believe TELA Bio is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is TELA or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to TELA Bio's net margin of -51.53%. Titan Medical's return on equity of -82.31% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -51.53% -1,320.81% -59.39% Titan Medical N/A -82.31% -51.47%

Titan Medical (TMDIF) Competitors

$0.11 +0.00 (+0.09%)

As of 09/22/2026

Compare

TMDIF vs. MDAI, SRTS, POCI, BDMD, and TELA

Should you buy Titan Medical stock or one of its competitors? Titan Medical's main competitors and comparable companies include Spectral AI (MDAI), Sensus Healthcare (SRTS), Precision Optics (POCI), Baird Medical Investment (BDMD), and TELA Bio (TELA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Titan Medical compare to Spectral AI?

Titan Medical (NASDAQ:TMDIF) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled Spectral AI'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Spectral AI	Neutral

Spectral AI has a consensus price target of $4.00, indicating a potential upside of 140.96%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts clearly believe Spectral AI is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 13.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market.

Titan Medical has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Spectral AI	-69.27%	N/A	-78.56%

Titan Medical has higher earnings, but lower revenue than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.71	$6.95M	$0.05	2.20
Spectral AI	$19.65M	2.72	-$7.57M	-$0.35	N/A

Summary

Spectral AI beats Titan Medical on 9 of the 15 factors compared between the two stocks.

How does Titan Medical compare to Sensus Healthcare?

Titan Medical (NASDAQ:TMDIF) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Titan Medical has a net margin of 0.00% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

Titan Medical has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.71	$6.95M	$0.05	2.20
Sensus Healthcare	$17.51M	2.85	-$7.72M	-$0.94	N/A

Titan Medical has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market.

In the previous week, Sensus Healthcare had 2 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for Sensus Healthcare and 0 mentions for Titan Medical. Sensus Healthcare's average media sentiment score of 0.51 beat Titan Medical's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Titan Medical	Neutral
Sensus Healthcare	Positive

Sensus Healthcare has a consensus target price of $5.83, indicating a potential upside of 92.52%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Sensus Healthcare beats Titan Medical on 10 of the 16 factors compared between the two stocks.

How does Titan Medical compare to Precision Optics?

Titan Medical (NASDAQ:TMDIF) and Precision Optics (NASDAQ:POCI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

In the previous week, Precision Optics had 2 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for Precision Optics and 0 mentions for Titan Medical. Titan Medical's average media sentiment score of 0.00 equaled Precision Optics'average media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Precision Optics	Neutral

Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, meaning that its share price is 68% less volatile than the broader market.

Titan Medical has higher earnings, but lower revenue than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.71	$6.95M	$0.05	2.20
Precision Optics	$19.09M	2.73	-$5.78M	-$0.63	N/A

0.0% of Titan Medical shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 0.0% of Titan Medical shares are held by company insiders. Comparatively, 14.4% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Titan Medical has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Precision Optics	-17.03%	-37.47%	-19.96%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Precision Optics beats Titan Medical on 8 of the 13 factors compared between the two stocks.

How does Titan Medical compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMD) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation.

Baird Medical Investment has a beta of -1.15, indicating that its stock price is 215% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Titan Medical has lower revenue, but higher earnings than Baird Medical Investment.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	1.48	N/A	N/A	N/A
Titan Medical	$17.63M	0.71	$6.95M	$0.05	2.20

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Baird Medical Investment's return on equity of 0.00% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Titan Medical	N/A	-82.31%	-51.47%

In the previous week, Baird Medical Investment had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Baird Medical Investment and 0 mentions for Titan Medical. Baird Medical Investment's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
Baird Medical Investment	Neutral
Titan Medical	Neutral

Summary

Baird Medical Investment beats Titan Medical on 8 of the 9 factors compared between the two stocks.

How does Titan Medical compare to TELA Bio?

TELA Bio (NASDAQ:TELA) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

Titan Medical has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$79.91M	0.73	-$38.83M	-$0.77	N/A
Titan Medical	$17.63M	0.71	$6.95M	$0.05	2.20

Titan Medical has a net margin of 0.00% compared to TELA Bio's net margin of -51.53%. Titan Medical's return on equity of -82.31% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-51.53%	-1,320.81%	-59.39%
Titan Medical	N/A	-82.31%	-51.47%

TELA Bio has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

94.3% of TELA Bio shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 1.1% of TELA Bio shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, TELA Bio had 6 more articles in the media than Titan Medical. MarketBeat recorded 6 mentions for TELA Bio and 0 mentions for Titan Medical. TELA Bio's average media sentiment score of 1.35 beat Titan Medical's score of 0.00 indicating that TELA Bio is being referred to more favorably in the media.

Company	Overall Sentiment
TELA Bio	Positive
Titan Medical	Neutral

TELA Bio presently has a consensus target price of $2.20, indicating a potential upside of 69.23%. Given TELA Bio's stronger consensus rating and higher probable upside, equities analysts plainly believe TELA Bio is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

TELA Bio beats Titan Medical on 10 of the 16 factors compared between the two stocks.

Get Titan Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMDIF vs. The Competition

Export

Metric	Titan Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$12.52M	$5.58B	$7.31B	$13.29B
Dividend Yield	N/A	1.79%	2.52%	12.57%
P/E Ratio	-0.09	25.26	274.08	25.69
Price / Sales	0.71	71.56	638.21	78.99
Price / Cash	0.02	33.02	77.80	52.76
Price / Book	0.10	5.78	10.47	6.32
Net Income	$6.95M	$151.55M	$3.49B	$359.73M
7 Day Performance	5.58%	-0.01%	-0.67%	0.17%
1 Month Performance	-22.78%	-3.53%	-3.17%	-3.27%
1 Year Performance	-68.28%	6.37%	15.14%	5.58%

Titan Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMDIF Titan Medical	N/A	$0.11 +0.1%	N/A	-68.3%	$12.52M	$17.63M	N/A	50
MDAI Spectral AI	1.7954 of 5 stars	$1.62 +0.9%	$4.00 +147.7%	-30.0%	$51.99M	$19.65M	N/A	83
SRTS Sensus Healthcare	3.069 of 5 stars	$3.13 -0.8%	$5.83 +86.7%	-4.1%	$51.44M	$27.48M	N/A	40
POCI Precision Optics	0.5159 of 5 stars	$4.39 +0.6%	N/A	+4.5%	$47.97M	$19.09M	N/A	80	News Coverage
BDMD Baird Medical Investment	0.9121 of 5 stars	$1.11 +0.5%	N/A	-68.1%	$46.64M	$22.54M	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMDIF) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Titan Medical (TMDIF) Competitors

TMDIF vs. MDAI, SRTS, POCI, BDMD, and TELA

How does Titan Medical compare to Spectral AI?

Summary

How does Titan Medical compare to Sensus Healthcare?

Summary

How does Titan Medical compare to Precision Optics?

Summary

How does Titan Medical compare to Baird Medical Investment?

Summary

How does Titan Medical compare to TELA Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDIF vs. The Competition

Titan Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Titan Medical (TMDIF) Competitors

TMDIF vs. MDAI, SRTS, POCI, BDMD, and TELA

How does Titan Medical compare to Spectral AI?

Does the media prefer TMDIF or MDAI?

Do analysts prefer TMDIF or MDAI?

Do insiders and institutionals believe in TMDIF or MDAI?

Which has more volatility and risk, TMDIF or MDAI?

Is TMDIF or MDAI more profitable?

Which has better valuation & earnings, TMDIF or MDAI?

Summary

How does Titan Medical compare to Sensus Healthcare?

Do institutionals & insiders have more ownership in TMDIF or SRTS?

Is TMDIF or SRTS more profitable?

Which has better valuation & earnings, TMDIF or SRTS?

Which has more volatility & risk, TMDIF or SRTS?

Does the media prefer TMDIF or SRTS?

Do analysts recommend TMDIF or SRTS?

Summary

How does Titan Medical compare to Precision Optics?

Does the media prefer TMDIF or POCI?

Which has more risk & volatility, TMDIF or POCI?

Which has preferable valuation & earnings, TMDIF or POCI?

Do insiders and institutionals believe in TMDIF or POCI?

Is TMDIF or POCI more profitable?

Do analysts recommend TMDIF or POCI?

Summary

How does Titan Medical compare to Baird Medical Investment?

Which has more risk & volatility, BDMD or TMDIF?

Do analysts recommend BDMD or TMDIF?

Which has higher earnings & valuation, BDMD or TMDIF?

Do insiders and institutionals believe in BDMD or TMDIF?

Is BDMD or TMDIF more profitable?

Does the media favor BDMD or TMDIF?

Summary

How does Titan Medical compare to TELA Bio?

Which has stronger valuation and earnings, TELA or TMDIF?

Is TELA or TMDIF more profitable?

Which has more volatility & risk, TELA or TMDIF?

Do institutionals & insiders have more ownership in TELA or TMDIF?

Does the media favor TELA or TMDIF?

Do analysts rate TELA or TMDIF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDIF vs. The Competition

Titan Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools